Marketing In Brief
This article was originally published in The Rose Sheet
Executive Summary
Revance Therapeutics: Biopharmaceutical company announces launch of Relastin Eye Silk, a topical product designed to increase the elasticity of skin around eyes. Item is "the first product to clinically demonstrate the ability to restore the 'spring'" of skin by "promot[ing] the formation of functional elastin," a protein in skin that the body stops producing as one ages. In clinical studies Relastin Eye Silk, which features the patent-pending Zinc Firming Complex, was shown to "significantly decrease" fine lines and wrinkles, coarse wrinkles, and under-eye laxity, puffiness and dark circles after four weeks of use, the Mountain View, Calif. firm says. Niquette Hunt, VP of cosmetic and OTC products for Revance Therapeutics, states: "These findings give us the opportunity to provide skin-care products that actually work at the cellular level to decrease the visible signs of aging." Relastin Eye Silk retails for $69